News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 183 results

Scientists want CRISPR regulation amid reports of foetus gene-editing

China26-11-2018

Scientists have urged policymakers to implement a regulatory framework governing the use of CRISPR technology in humans, following reports that a Chinese scientist has successfully created ‘edited’ twins.

CRISPR tech market to reach $1.72m by 2023: report

International23-11-2018

The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.

Life sciences partners join Saul Ewing’s Boston office

US23-11-2018

Saul Ewing Arnstein & Lehr has strengthened its Boston office with the addition of two life sciences partners from Hamilton, Brook, Smith & Reynolds.

10x Genomics sued over cell research tools

US20-11-2018

Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools.

CRISPR Therapeutics expands MaxCyte partnership into immuno-oncology

US13-11-2018

Gene-editing company CRISPR Therapeutics has expanded its partnership with US-based MaxCyte, which focuses on cell-based medicines, into the immuno-oncology arena. 

BMS company not required to pay damages in trade secrets case

US12-11-2018

A jury has said that Flexus Biosciences, a company owned by Bristol-Myers Squibb, does not need to pay damages despite being liable for trade secrets misappropriation.

HGF hires former Roivant Sciences VP

Switzerland05-11-2018

HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner.

Illumina buys rival Pacific Biosciences for $1.2bn

US02-11-2018

Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion. 

ERS Genomics licenses CRISPR patents to Cambridge University spin-out

EU, UK01-11-2018

The company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, ERS Genomics, has signed a patent licensing deal with DefiniGEN, a spin-out from the University of Cambridge, UK.

Nelson Mullins adds life sciences litigator in NYC

US26-10-2018

Siew Yen Chong has joined Nelson Mullins Riley & Scarborough’s New York office as of counsel.

Showing 1 to 10 of 183 results

LSIPR